These benefits, along with a previous report displaying that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,two aid the concept of focusing on ACKR3 as a unique technique to modulate the opioid procedure, which could open new therapeutic avenues for opioid-associated Conditions.Conolidine CONOCB2™ fundamentally pe